Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
September 4, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-004618.pdf 0001562180-19-004618.rtf View HTML
August 8, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-216112.pdf 0001193125-19-216112.rtf 0001193125-19-216112.xls View HTML
August 8, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-19-030771.pdf 0001564590-19-030771.rtf 0001564590-19-030771.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
August 8, 2019	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-19-216938.pdf 0001193125-19-216938.rtf 0001193125-19-216938.xls View HTML
August 5, 2019	3	Initial filing by director officer or owner of more than ten percent.	0001562180-19-004168.pdf 0001562180-19-004168.rtf View HTML
June 11, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-170194.pdf 0001193125-19-170194.rtf 0001193125-19-170194.xls View HTML
June 10, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003432.pdf 0001562180-19-003432.rtf View HTML
June 10, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003434.pdf 0001562180-19-003434.rtf View HTML
June 10, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003437.pdf 0001562180-19-003437.rtf View HTML
June 10, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003438.pdf 0001562180-19-003438.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax